1-3 of 3
Kazimierz Kuliczkowski, Professor
Close
Sort by
Journal Articles

Symptom Burden and Health-Related Quality Of Life (HRQoL) In Patients With Myelofibrosis (MF) Treated With Fedratinib (SAR302503) In a Phase III Study (JAKARTA)

Ruben A. Mesa, MD, Jorge E. Cortes, MD, Francisco Cervantes, MD, Donald Milligan, MD, FRCP, FRCPath, Tamás Masszi, MD, PhD, Elena Mishchenko, MD, Eric Jourdan, MD PhD, Alessandro M. Vannucchi, MD, Mark Drummond, MD PhD, Mindaugas Jurgutis, MD, Kazimierz Kuliczkowski, Professor, Emanuil Gheorghita, MD, Francesco Passamonti, MD, Frank Neumann, Florence Joulain, MSc, Sheikh Usman Iqbal, MD MPH MBA, Claire N Harrison, DM, FRCP, FRCPath
Journal: Blood
Blood (2013) 122 (21): 4061.
https://doi.org/10.1182/blood.V122.21.4061.4061
Published: 2013
Journal Articles

CD117 (c-kit) Expression On CD34+ Cells Participates In The Cytogenetic Response To Imatinib In CML Patients In First Chronic Phase

Jaroslaw Dybko, MD PhD, Ewa Medras, MD, Olga Haus, MD, PhD, Prof., Bozena Jazwiec, MSC, Joanna Urbaniak, PhD, Mieczyslaw Wozniak, PhD Prof., Kazimierz Kuliczkowski, Professor
Journal: Blood
Blood (2013) 122 (21): 3990.
https://doi.org/10.1182/blood.V122.21.3990.3990
Published: 2013
Journal Articles

A Randomized, Multicenter Study (PALG CLL4/ ML 21283) Of Maintenance Treatment With Rituximab Versus Observation After Induction Treatment With Rituximab, Cladribine, and Cyclophosphamide (RCC) Regimen In Patients With Progressive Chronic Lymphocytic Leukemia: Interim Analysis

Tadeusz Robak, Jerzy Z. Blonski, MD, PhD, Krzysztof Jamroziak, MD, PhD, Aleksander Skotnicki, Professor, Magdalena Piotrowska, MD, Anatoly Uss, Professor, Janusz Kloczko, Professor, Jaroslaw Piszcz, Kazimierz Kuliczkowski, Professor, Tomasz Wrobel, MD PhD, Bozena Katarzyna Budziszewska, MD, PhD, Marta Fidecka, Piotr Smolewski, Professor
Journal: Blood
Blood (2013) 122 (21): 1640.
https://doi.org/10.1182/blood.V122.21.1640.1640
Published: 2013